Literature DB >> 31323587

Degradation of pharmaceutical compounds in water by oxygenated electrochemical oxidation: Parametric optimization, kinetic studies and toxicity assessment.

Josué Daniel García-Espinoza1, Petia Mijaylova Nacheva2.   

Abstract

The pharmaceutical compounds sulfamethoxazole (SMX), propranolol (PRO) and carbamazepine (CBZ) are biorecalcitrant and frequently detected in waters causing negative impacts on human health and aquatic organisms. Electrochemical oxidation appears as an effective option for the removal of recalcitrant compounds and its enhancement is an important issue for the removal of emerging compounds in water. The contribution of this research lies in the comprehensive analysis of the oxygenated electro chemical oxidation of CBZ, SMX and PRO using Nb/BDD mesh anode. The effect of treatment time, current, pH and oxygen injection on the SMX, PRO and CBZ degradation was assessed using Na2SO4 as electrolyte, process optimization was performed, by-products were identified, kinetic and toxicity tests were carried out using different electrolytes. Finally, the process effectiveness was tested using real secondary effluent spiked with the mixture of the pharmaceutical compounds and the acute toxicity was determined. The obtained results indicated that the oxygenated electrochemical oxidation allows effective simultaneous SMX, PRO and CBZ degradation, which showed a significant dependence of treatment time, current and oxygen injection in Na2SO4 electrolyte. At 90 min of electrolysis the parent compounds were detected as well as eight by-products. At 150 min of treatment, further to the already determined by-products and the parent compounds, appeared phenol and p-benzoquinone. Based on the identified compounds, degradation pathways were explained as a result of two main mechanisms: transformation (hydroxylation, deamination, desulfunation) and bond rupture. The kinetic study indicated an increase of the first-order kinetic constant in the oxygenated electrochemical oxidation process using Na2SO4 and NaBr as electrolyte, nevertheless the constant decreased in the presence of NaCl. In the assays with secondary effluent spiked with SMX, PRO and CBZ, the oxygenation did not enhance the performance of the process, however; pharmaceuticals were degraded with a higher removal rates compared with the ones determined in the Na2SO4 synthetic solutions assays; the oxygenation enhanced the TOC and COD removal. The acute toxicity of spiked secondary effluent was reduced from the first few minutes of the electrochemical oxidation process.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Electrochemical oxidation; Indirect oxidation; Nb/BDD; Pharmaceuticals; Reactive oxygen species

Mesh:

Substances:

Year:  2019        PMID: 31323587     DOI: 10.1016/j.scitotenv.2019.07.118

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  4 in total

1.  Microbial Electrochemical Fluidized Bed Reactor: A Promising Solution for Removing Pollutants From Pharmaceutical Industrial Wastewater.

Authors:  Yeray Asensio; María Llorente; Alejandro Sánchez-Gómez; Carlos Manchon; Karina Boltes; Abraham Esteve-Núñez
Journal:  Front Microbiol       Date:  2021-11-26       Impact factor: 5.640

2.  Synergistic advanced oxidation process for enhanced degradation of organic pollutants in spent sulfuric acid over recoverable apricot shell-derived biochar catalyst.

Authors:  Jinling Zhang; Xin Jin; Hui Zhao; Chaohe Yang
Journal:  RSC Adv       Date:  2022-01-12       Impact factor: 3.361

Review 3.  A sustainable approach for the removal methods and analytical determination methods of antiviral drugs from water/wastewater: A review.

Authors:  Bahriye Eryildiz; Bahar Yavuzturk Gul; Ismail Koyuncu
Journal:  J Water Process Eng       Date:  2022-08-08

Review 4.  A review on disinfection methods for inactivation of waterborne viruses.

Authors:  Adedayo Ayodeji Lanrewaju; Abimbola Motunrayo Enitan-Folami; Saheed Sabiu; Feroz Mahomed Swalaha
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.